/PRNewswire/ According to Coherent Market Insights, the global recombinant protein market is estimated to be valued at US$ 494.7 million in 2022 and is.
Global Recombinant Protein Market to Surpass US$ 806 0 Million by 2030 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ According to Coherent Market Insights, the global recombinant protein market is estimated to be valued at US$ 494.7 million in 2022 and is.
Search jobs 16-Feb-2021 Recombinant Protein Market Size Is Elastomers to Grow By 6.2% CAGR by 2025 | Global Industry Demand by Product, Application, Diagnostic Services and Treatment
Recombinant Protein Market – Insights
Recombinant proteins are used in development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology. Depending on the type of the protein, recombinant proteins are classified into hormones, growth factor, cytokines, plasma protein factor, recombinant metabolic enzymes, and others. Manufacturers such as Biocon, Ltd., Eli, Lilly, and Company, Genentech, Inc., Novo Nordisk Pharmatech A/S, Prospec-Tany Technogene Ltd., Abcam plc, and BPS Bioscience, Inc. offer recombinant proteins for various applications such as drug discovery and development. Advancements in rDNA technology such as Cl